Interpace Diagnostics Group Reports First Quarter 2017 Financial Results, Business Progress and Recent Accomplishments

Go back to Interpace Diagnostics Group Reports First Quarter 2017 Financial Results, Business Progress and Recent Accomplishments

Interpace Diagnostics (IDXG) Reports Q1 EPS of $0.42

May 15, 2017 8:54 AM EDT

Interpace Diagnostics (NASDAQ: IDXG) reported Q1 EPS of $0.42, versus ($2.26) reported last year. Revenue for the quarter came in at $3.5 million, versus $3.04 million reported last year.

For earnings history and earnings-related data on Interpace Diagnostics (IDXG) click here.

... More